Omni Peptides
KLOW Blend
Couldn't load pickup availability

KLOW Blend (also known as Klow Stack or Radiance Recovery Blend) is a synthetic multi-peptide formulation combining BPC-157, TB-500 (Thymosin Beta-4), KPV, and GHK-Cu in a single lyophilized vial (commonly totaling 80 mg, with typical ratios such as BPC-157 10 mg, TB-500 10 mg, KPV 10 mg, GHK-Cu 50 mg). This research blend has garnered significant attention in preclinical regenerative studies for its synergistic potential to address tissue repair, inflammation resolution, immune modulation, and extracellular matrix remodeling through complementary pathways. It builds on simpler blends like Wolverine (BPC-157 + TB-500) by incorporating KPV for enhanced anti-inflammatory effects and GHK-Cu for collagen synthesis and dermal/tissue rejuvenation. Researchers employ KLOW Blend in laboratory and animal models to investigate multi-target regenerative mechanisms, particularly in injury recovery, chronic inflammation, wound healing, and age-related tissue decline. As a research-grade compound, KLOW Blend is intended exclusively for in vitro and animal studies. Scientists value its broad-spectrum approach, combining cytoprotective, angiogenic, actin-regulatory, and copper-mediated signaling for comprehensive tissue restoration research.
Research Applications
Storage & Handling
Storage & Handling
Lyophilised vials are stable at −20°C for up to 2 years unopened. Once reconstituted, refrigerate at 2–8°C and use within 28 days. Avoid repeated freeze-thaw cycles.
Beyond Use Date
Pre-filled formats (cartridge, pen, nasal) carry a beyond-use date of typically 4–8 weeks from receipt. ≥98% purity by HPLC. For in vitro and preclinical research use only — not for human or veterinary use.
— About this compound
KLOW Blend is a combined regenerative peptide blend.
KLOW Blend (also known as Klow Stack or Radiance Recovery Blend) is a synthetic multi-peptide formulation combining BPC-157, TB-500 (Thymosin Beta-4), KPV, and GHK-Cu in a single lyophilized vial (commonly totaling 80 mg, with typical ratios such as BPC-157 10 mg, TB-500 10 mg, KPV 10 mg, GHK-Cu 50 mg). This research blend has garnered significant attention in preclinical regenerative studies for its synergistic potential to address tissue repair, inflammation resolution, immune modulation, and extracellular matrix remodeling through complementary pathways. It builds on simpler blends like Wolverine (BPC-157 + TB-500) by incorporating KPV for enhanced anti-inflammatory effects and GHK-Cu for collagen synthesis and dermal/tissue rejuvenation. Researchers employ KLOW Blend in laboratory and animal models to investigate multi-target regenerative mechanisms, particularly in injury recovery, chronic inflammation, wound healing, and age-related tissue decline. As a research-grade compound, KLOW Blend is intended exclusively for in vitro and animal studies. Scientists value its broad-spectrum approach, combining cytoprotective, angiogenic, actin-regulatory, and copper-mediated signaling for comprehensive tissue restoration research.
Four compounds, one formulation.
BPC-157C₆₂H₉₈N₁₆O₂₂
1419.5 g/mol
▾
TB-4C₂₁₂H₃₅₀N₅₆O₇₈S
4963.5 g/mol
▾
KPVC₁₆H₃₀N₄O₄
342.43 g/mol
▾
GHK-CuC₁₄H₂₂CuN₆O₄
401.9 g/mol
▾
Research Applications
Where researchers apply it.
— Verified & Documented
Every vial is backed by a Certificate of Analysis.
Each lot is independently characterised by HPLC and mass spectrometry, with identity, mass and purity documented per batch and available on request.
Additional quality-control testing, including sterility, endotoxin and heavy metals, is conducted periodically across our product range.
Storage & Handling
Storage & Handling
Lyophilised vials are stable at −20°C for up to 2 years unopened. Once reconstituted, refrigerate at 2–8°C and use within 28 days. Avoid repeated freeze-thaw cycles.
Beyond Use Date
Pre-filled formats (cartridge, pen, nasal) carry a beyond-use date of typically 4–8 weeks from receipt. ≥98% purity by HPLC. For in vitro and preclinical research use only — not for human or veterinary use.